Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1991 1
1992 2
1993 2
1994 1
1995 3
1996 2
1997 3
1998 2
2002 1
2011 1
2018 3
2019 1
2020 1
2021 2
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Cytochrome P450-2D6 activity in people with codeine use disorder.
Daglish MRC, Reilly SR, Mostafa S, Edwards C, O'Gorman TM, Hayllar JS. Daglish MRC, et al. Among authors: hayllar js. Pharmacogenomics J. 2023 Nov;23(6):195-200. doi: 10.1038/s41397-023-00319-6. Epub 2023 Nov 9. Pharmacogenomics J. 2023. PMID: 37940651 Free PMC article.
Sulphasalazine in ulcerative colitis: in memoriam?
Hayllar J, Bjarnason I. Hayllar J, et al. Gut. 1991 May;32(5):462-3. doi: 10.1136/gut.32.5.462. Gut. 1991. PMID: 1674925 Free PMC article. Review. No abstract available.
An overview of take-home naloxone programs in Australia.
Dwyer R, Olsen A, Fowlie C, Gough C, van Beek I, Jauncey M, Lintzeris N, Oh G, Dicka J, Fry CL, Hayllar J, Lenton S. Dwyer R, et al. Among authors: hayllar j. Drug Alcohol Rev. 2018 May;37(4):440-449. doi: 10.1111/dar.12812. Drug Alcohol Rev. 2018. PMID: 29744980
'I just thought that was the best thing for me to do at this point': Exploring patient experiences with depot buprenorphine and their motivations to discontinue.
Clay S, Treloar C, Degenhardt L, Grebely J, Christmass M, Gough C, Hayllar J, McDonough M, Henderson C, Crawford S, Farrell M, Marshall A. Clay S, et al. Among authors: hayllar j. Int J Drug Policy. 2023 May;115:104002. doi: 10.1016/j.drugpo.2023.104002. Epub 2023 Mar 30. Int J Drug Policy. 2023. PMID: 37003194 Free article.
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay.
Lamoury FMJ, Bajis S, Hajarizadeh B, Marshall AD, Martinello M, Ivanova E, Catlett B, Mowat Y, Marks P, Amin J, Smith J, Ezard N, Cock V, Hayllar J, Persing DH, Kleman M, Cunningham P, Dore GJ, Applegate TL, Grebely J; LiveRLife Study Group. Lamoury FMJ, et al. Among authors: hayllar j. J Infect Dis. 2018 May 25;217(12):1889-1896. doi: 10.1093/infdis/jiy114. J Infect Dis. 2018. PMID: 29534185
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.
Conway A, Valerio H, Alavi M, Silk D, Treloar C, Hajarizadeh B, Marshall AD, Martinello M, Milat A, Dunlop A, Murray C, Prain B, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Hayllar J, Reid D, Gorton C, Lam T, Christmass M, Wade A, Montebello M, Dore GJ, Grebely J; ETHOS Engage Study Group. Conway A, et al. Among authors: hayllar j. Viruses. 2022 Jul 16;14(7):1555. doi: 10.3390/v14071555. Viruses. 2022. PMID: 35891535 Free PMC article.
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study.
Wheeler A, Valerio H, Cunningham EB, Martinello M, Barocas JA, Colledge-Frisby S, Treloar C, Amin J, Henderson C, Read P, Matthews GV, Dunlop AJ, Gorton C, Hayllar J, Alavi M, Murray C, Marks P, Silk D, Degenhardt L, Dore GJ, Grebely J; ETHOS Engage Study Group. Wheeler A, et al. Among authors: hayllar j. Drug Alcohol Depend. 2022 Aug 1;237:109543. doi: 10.1016/j.drugalcdep.2022.109543. Epub 2022 Jun 26. Drug Alcohol Depend. 2022. PMID: 35772249
35 results